Normothermic renal artery perfusion: a comparison of perfusates.
Hypothermia and preservative perfusates have been used to decrease ischemic renal injury. This study was performed to identify the preservative function of perfusates independent of the effects of hypothermia. Rats underwent 45 minutes of renal ischemia. Rectal and renal parenchyma temperatures were monitored and maintained within 1 degree C of normal. Perfusates were University of Wisconsin solution (UW), Euro-Collins solution, normal saline solution, and Ringer's lactate solution. A nonperfused ischemic control and a nonischemic control group were also evaluated. Parameters evaluated included serum creatinine and blood urea nitrogen levels, renal ischemic injury grade, renal weight, and gross appearance of the injured kidney. Rats treated with UW solution were found to have a significantly lower creatinine, blood urea nitrogen, and injury grade than the other three perfused groups. The external gross appearance of the UW-treated kidneys was normal, whereas that of the other groups demonstrated moderate to severe injury. Although the mean right/left renal weight difference of the UW-treated group was lower than that of the other three groups, this was not statistically significant. Under normothermic conditions in rats, UW solution affords significant renal protection from ischemia. Euro-Collins, normal saline, and Ringer's lactate solutions display no significant protective effect.
Hughes
J D
JD
Department of Surgery, Emory University School of Medicine, Atlanta, Ga, USA.
Chen
C
C
Mattar
S G
SG
Someren
A
A
Noe
B
B
Suwyn
C R
CR
Lumsden
A B
AB
D000241:Adenosine / Q000627:therapeutic use; D000493:Allopurinol / Q000627:therapeutic use; D000818:Animals; D001806:Blood Urea Nitrogen; D001831:Body Temperature; D002314:Cardioplegic Solutions / Q000627:therapeutic use*; D003404:Creatinine / Q000097:blood; D005978:Glutathione / Q000627:therapeutic use; D006982:Hypertonic Solutions / Q000627:therapeutic use; D007036:Hypothermia, Induced; D007328:Insulin / Q000627:therapeutic use; D007511:Ischemia / Q000517:prevention & control; D007552:Isotonic Solutions / Q000627:therapeutic use; D007668:Kidney / Q000098:blood supply / Q000473:pathology / Q000601:surgery*; D008297:Male; D008991:Monitoring, Physiologic; D019188:Organ Preservation Solutions; D009929:Organ Size; D010477:Perfusion / Q000379:methods*; D011887:Raffinose / Q000627:therapeutic use; D051381:Rats; D017207:Rats, Sprague-Dawley; D012007:Rectum; D012077:Renal Artery; D000077325:Ringer's Lactate; D012965:Sodium Chloride; D014021:Tissue Preservation
D002314:Cardioplegic Solutions; C037096:Euro-Collins' solution; D006982:Hypertonic Solutions; D007328:Insulin; D007552:Isotonic Solutions; D019188:Organ Preservation Solutions; D000077325:Ringer's Lactate; C055206:University of Wisconsin-lactobionate solution; D012965:Sodium Chloride; D000493:Allopurinol; D003404:Creatinine; D005978:Glutathione; D000241:Adenosine; D011887:Raffinose